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Type VI secretion system mutations reduced
competitive ﬁtness of classical Vibrio cholerae
biotype
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The gram-negative bacterium Vibrio cholerae is the causative agent of the diarrhoeal disease
cholera and is responsible for seven recorded pandemics. Several factors are postulated to
have led to the decline of 6th pandemic classical strains and the rise of El Tor biotype V.
cholerae, establishing the current 7th pandemic. We investigated the ability of classical V.
cholerae of the 2nd and 6th pandemics to engage their type six secretion system (T6SS) in
microbial competition against non-pandemic and 7th pandemic strains. We report that
classical V. cholerae underwent sequential mutations in T6SS genetic determinants that
initially exposed 2nd pandemic strains to microbial attack by non-pandemic strains and
subsequently caused 6th pandemic strains to become vulnerable to El Tor biotype V. cholerae
intraspeciﬁc competition. The chronology of these T6SS-debilitating mutations agrees with
the decline of 6th pandemic classical strains and the emergence of 7th pandemic El Tor V.
cholerae.
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ibrio cholerae is a gram-negative bacterium and the
causative agent of the diarrhoeal disease cholera.
Throughout modern history, seven cholera pandemics
have been reported, all caused by pandemic strains of the
O1 serogroup. Understanding how these O1 pandemic strains
evolved is hampered by the absence of available strains. Historical
strains were not isolated until the germ theory became accepted
in the late 1800s. Furthermore, V. cholerae colonises soft tissues
and is noninvasive. Therefore, historical specimens for DNA
extraction are rare. As a result, DNA sequences are available
principally from the 6th pandemic (classical biotype strains,
1899–1923) and the ongoing 7th pandemic (El Tor biotype
strains, 1961–today). A preserved intestine from an 1849 cholera
victim belonging to the Mütter Museum collection in Philadelphia offers unprecedented insights into 2nd pandemic V. cholerae
(Supplementary Fig. 7)1. The generation of a high-resolution
genomic sequence allowed us to track the evolution of one V.
cholerae virulence factor, the type-six secretion system (T6SS)2.
The T6SS is a bacterial nanomachine embedded in the envelope of gram-negative bacteria that mediates contact-dependent
translocation of effector toxins into neighbouring cells2. Contraction of the T6SS outer sheath ejects an inner tube consisting
of polymerised Hcp proteins, capped with effector proteins, into
adjacent bacteria. These effectors are toxic unless inhibited by
cognate immunity proteins in the attacked bacterium. Three
distinct genetic loci across two chromosomes encode the T6SS in
V. cholerae: auxiliary cluster 1, auxiliary cluster 2 and a large
cluster, each harbouring an effector-immunity pair: tseL & tsiV1,
vasX & tsiV2 and vgrG3 & tsiV3, respectively. Effector and
immunity pairs must have evolved in tandem with a cognate
immunity protein for each effector. Each immunity protein
protects only against a single cognate effector because crossresistance has not been observed3.
Based on the similarity of TsiV1, TsiV2 and TsiV3 at each
locus in 6th and 7th pandemic strains, we initially classiﬁed all
6th pandemic strains into the same compatibility group as the
AAA-7th pandemic strains3. Compatibility groups were named as
follows: the ﬁrst A refers to TsiV1 (Axx), the second A to TsiV2
(xAx) and the third A to TsiV3 (xxA). Divergent alleles at each
locus were named in the order of discovery (A, B, C, D, etc.) for
the auxiliary 1, 2 or large cluster, respectively, giving rise to 27
currently known compatibility groups in V. cholerae3. Compatibility groups were further classiﬁed into subfamilies to account
for distinct TsiV1 amino acid sequences among the same modules: the 6th pandemic classical strains are represented by compatibility groups A1A1A1 (e.g. strain NIH41), A2A1A1 (e.g. strains
CA401 and O395) and A3A1A1 (MZO-2); A4A1A1 (e.g. strain
A59) was identiﬁed in this study. Members of the same compatibility group are immune to or compatible with each other3, as
homologous immunity proteins deﬁne compatibility groups. In
contrast, V. cholerae strains that do not encode the same effector
and immunity genes will compete and are considered to be
incompatible. Pandemic strains are subdivided into two biotypes;
the seventh pandemic V. cholerae O1 El Tor biotype and the sixth
pandemic O1 classical biotype, which evolved as distinct
lineages4–8. The causes that led the 7th pandemic El Tors to
replace classical strains as the source of pandemic cholera
remains an intense research area. Three main hypotheses support
classical biotype displacement: distinct virulence gene regulation,
additional virulence factors encoded by El Tor V. cholerae, and
biotype-speciﬁc phenotypic differences9–11. For example, El Tor
and classical strains regulate ~1 in 8 genes differently, resulting in
biotype-speciﬁc spatial-temporal expression of the main virulence
factors, cholera toxin (CT) and toxin-coregulated pilus (TCP)9,10.
Numerous additional virulence factors encoded within El Tor
genomes are either absent or differentially regulated in classical
2

Vibrio cholerae strains, including the Vibrio seventh pandemic
island 1 (VSP-I) and 2 (VSP-II), HlyA, PilE, MSHA and RTX.
Phenotypically, the El Tor biotype displays increased bioﬁlm
production and motility compared to classical strains8–11. Lastly,
lytic phages are speciﬁc to either of the two biotypes, inviting the
hypothesis that phage population ﬂuctuations could have contributed to the biotype replacement7,12,13. El Tor strains cause a
less virulent form of cholera accompanied by a more extended
period of bacterial shedding14–16, likely due to the considerable
differences between the biotypes described above, thereby beneﬁting the pathogen by increasing dissemination time16.
We investigated differences in the DNA sequences encoding
T6SS genes of classical and El Tor biotype V. cholerae to improve
understanding of how bacterial competition plays in cholera’s
pathogenesis. In this work, we examined three aspects of competitiveness across pandemic cholera strains: the ability to engage
in T6SS battle with commensal bacteria, compete with nonpandemic strains and compete with other pandemic strains.
Results
2nd and 6th pandemic classical V. cholerae encode polymorphic T6SS. The draft genome of the 2nd cholera pandemic
classical strain PA1849 isolated from a preserved intestine stored
at the Mütter Museum in Philadelphia was recently sequenced1.
Because the sequencing effort was not designed to provide sufﬁcient sequencing depth to cover the entire T6SS gene clusters,
we designed speciﬁc booster probes for the enrichment and
adequate coverage of these loci. Re-sequencing the microbial
content from the same Mütter Museum specimen provided an
average coverage depth of ~300x across the T6SS gene clusters
(Fig. 1).
An earlier analysis of the three T6SS genetic loci of the 6th
pandemic classical V. cholerae strain O395 (isolated in India in
1965) revealed frameshift mutations in the large gene cluster17.
Therefore, we conducted a comparative analysis of the resequenced T6SS clusters from the 2nd pandemic strain PA1849
and the 6th pandemic classical strain O395. T6SS sequences from
each genome were aligned with those of the El Tor reference
strain C6706. The 2nd and the 6th classical pandemic strains
PA1849, and O395 encode a 12-nucleotide deletion (Δ293-304) in
VCA0109 renamed vasN. In addition, the 6th pandemic classical
strain O395 harbours an 8-nucleotide frameshift mutation (Δ514521) in the structural gene vasK (VCA0120), one singlenucleotide polymorphism (SNP) in the effector tseL, and another
SNP in its cognate immunity gene tsiV1 (Fig. 1). Evaluation of
available 6th pandemic classical strain T6SS sequences showed
that additional frameshift mutations in the large cluster’s vipA
(VCA0107) and vasE (VCA0114) genes are shared among all 6th
pandemic strains (Supplementary Fig. 1). Next, we investigated
the impact of these mutations on T6SS activity in classical biotype
strains.
The T6SS of 2nd and 6th pandemic classical strains is disabled.
VipA–VipB complexes constitute the contractile outer sheath of
the T6SS18. Similarly, VasK (TssM in Escherichia coli) links the
outer membrane protein TssJ with the inner membrane protein
TssL, forming the membrane core complex of the T6SS19. Deletions of vipA, vasE or vasK in strain V52, which constitutively
expresses the T6SS, abolish Hcp secretion (the hallmark of a
functional T6SS) and abrogate T6SS-mediated killing2,20. Therefore, the mutations highlighted in Fig. 1 and Supplementary Fig. 1
result in truncations of these genes and are prone to disable T6SS
activity. Furthermore, the vasN in-frame deletion removes four
amino acids in VasN, a structural protein essential for Hcp
secretion and T6SS function in general20.
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Fig. 1 The T6SS gene clusters of the classical V. cholerae strain PA1849. A Illumina-generated reads were mapped to a 6th pandemic classical strain
(O395) and a 7th pandemic El Tor V. cholerae strain (C6706). Read coverage plotted against the nucleotide sequence of the three T6SS gene clusters
(shown as light blue arrows in panel (B)) separated by white vertical lines that indicate the intervening genomic sequences not included in this analysis.
The top plot (grey) represents read coverage against the O395 reference, and the bottom plot (grey) represents read coverage against the C6706
reference. B Nucleotide alignment of the three T6SS clusters (bottom light blue arrows) from PA1849, O395 and C6706. The top black bars, representing
the PA1849 T6SS clusters, are designated as the reference sequences. Conserved residues in O395 and C6706 sequences are represented by grey bars
with single-nucleotide polymorphisms (SNPs) highlighted by vertical black lines and insertions or deletions (INDELS) of base pairs represented by gaps
with horizontal black dashes. C A schematic gene map for each T6SS gene cluster displays structural genes as blue arrows and effector/immunity pairs as
red arrows. Zoomed alignments of regions of interest in strains C6706, O395 and PA1849 are shown. Hyphens in the alignment indicate deleted
nucleotides (above) and amino acids (below). Nucleotides and their corresponding amino acid changes are coloured. Multiple colours are used to indicate
the new reading frame for the vasK frameshift mutation. Reads mapping to the vasN deletion are shown in the Supplementary material (Supplementary
Fig. 10).

To test whether these polymorphisms restrict the ability of 2nd
and 6th pandemic strains to outcompete microbial opponents,
we introduced the classical alleles from PA1849 into V. cholerae
strain V52 with an El Tor T6SS (the V52 T6SS structural
components share 99.2% amino acid identity with 7th
pandemic El Tor strains such as C670617). This experiment
allowed us to determine whether the mutations found in
classical strains interfere with T6SS activity while bypassing
potential strain-speciﬁc regulatory differences21. Streptomycinresistant V. cholerae V52 with the vasKΔ514-521 allele from the 6th
pandemic classical strains or with the vasNΔ293-304 allele from
2nd and 6th pandemic classical strains were incubated with
rifampicin-resistant E. coli (see ‘Methods’ for details). The vasK
Δ514-521 and the vasNΔ293-304 V52 strains lost T6SS activity
and did not kill E. coli comparably to the ΔvasK mutant
control (Fig. 2). As reported for previous experiments21, wildtype V52 yielded ~1000-fold killing of E. coli. The deleted
Arginine, Valine, Leucine and Valine residues in the classical
vasNΔ293-304 allele is adjacent to a residue essential for VasN
function in Pseudomonas aeruginosa22 (Supplementary Fig. 2). In
V. cholerae, these four amino acids are located within a β-strand
and are likely to disrupt its secondary structure (Supplementary
Fig. 2).
Taken together, these results suggest that the deletion in vasN
present in both 2nd and 6th pandemic strains disabled the T6SS,
permitting the accumulation of additional T6SS-disabling mutations, including a premature stop codon in vasK (vasKΔ514-521) in
6th pandemic strains.

A subset of 6th pandemic classical V. cholerae strains is sensitive to T6SS-mediated attack by bacteria belonging to the
same compatibility group. Compatibility groups comprise V.
cholerae strains encoding the same T6SS effector and immunity
alleles, rendering them immune to reciprocal T6SS-mediated
attack and permitting coexistence3. Comparative sequence analysis of compatibility groups revealed that TsiV2 and TsiV3 of 6th
pandemic strains are identical to their counterparts in C6706
(Supplementary Fig. 3B, C). Comparison of classical TsiV1 amino
acid sequences with those of El Tor strains revealed an overall
sequence identity of 98.8%. Visualisation of the alignment in a
radial tree differentiated four clades of TsiV1 sequences (Fig. 3A).
The four polymorphic TsiV1 amino acid sequences vary at
positions Leu4Phe, Ile163Phe and Ala237Thr in four different
permutations (Fig. 3B) based on single nucleotide substitutions
T12G, A487T or G709A in tsiV1, giving rise to compatibility
groups A1–A4, respectively.
We compared V. cholerae TseL (Supplementary Fig. 3A) to
determine whether the polymorphisms observed in TsiV1 amino
acid sequences are matched in the cognate effector because
immunity protein TsiV1 inhibits TseL effector-mediated T6SS
killing3,23. The alignment reveals that four TseL alleles are present
in the analysed classical V. cholerae genomes: 10 out of the
26 strains encode an identical TseL to the allele found in C6706,
14 out of 26 strains differ by a single Tyr528His amino acid
substitution, 1 out of 26 differs by both Tyr528His and an
additional Ala98Gly substitution and 1 out of 26 is uniquely
truncated. Therefore, TseL has undergone sequential mutations
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Fig. 2 Classical alleles of vasK and vasN disable the T6SS. A deletion
within vasN present in 2nd and 6th pandemic strains, or a deletion in vasK
found in 6th pandemic strains were constructed in V. cholerae V52. Strains
were assayed for killing E. coli MG1655 to determine T6SS function. Wildtype V52 was used as the positive control and V52ΔvasK as the negative
control. Killing assays were performed for 4 h at 37 °C. Mean ± standard
deviation of n = 3 biologically independent experiments, each performed in
duplicate, is shown. Horizontal bars represent the mean and error bars
represent the standard deviation. Statistical signiﬁcance was determined by
ordinary one-way ANOVA with Tukey’s multiple comparisons test
(****p < 0.0001, **p = (0.0024, 0.0014), ns = not signiﬁcant). Source data
are provided as a Source Data ﬁle.

over time: no change from PA1849 to CA401, Tyr528His
introduced at A57 and the additional Ala98Gly mutation in
A279. These results suggest that the mutation of TseL
accompanied the mutation of TsiV1 in 6th pandemic strains
examined here.
Whether strains with immunity proteins of the same family
(e.g. A) but different subfamilies (e.g. A1, A2) are immune to each
other was experimentally determined next. To test the ability of
6th pandemic V. cholerae to coexist with other strains of the AAA
compatibility family, O395 (A2A1A1), CA401 (A2A1A1) and
NIH41 (A1A1A1) were competed against strain V52 (A1A1A1) or
V52ΔvasK (Fig. 3C). T6SS activity of V52 led to an ~10-fold
decrease in the number of surviving O395 and CA401 bacteria; in
contrast, NIH41 was recovered in equal numbers regardless of
exposure to wild-type V52 or V52ΔvasK, indicating full immunity
against T6SS-mediated attack by other members of the A1A1A1
compatibility group. Similar numbers of compatible C6706
(A1A1A1) survived exposure to V52 or V52ΔvasK resulting in a
competitive index of ~1. The competitive index of incompatible
AM-19226 (C1D4F1) that survive exposure to V52 was ~104-fold
lower, and the competitive index of AM-19226 surviving
exposure to V52ΔvasK was ~103-fold higher (Fig. 3C).
Next, we evaluated TsiV1 immunity gene expression proﬁles to
determine whether the observed sensitivity of A2A1A1 classical V.
cholerae to T6SS-mediated attack by strains of the A1A1A1
compatibility group is due to transcriptional variation. TsiV1
expression levels determined by qPCR in select strains did not
explain the difference in susceptibility; for example, although
O395’s immunity is compromised (Fig. 3C), this strain displayed
the highest tsiV1 transcript levels (Supplementary Fig. 4).
4

TsiV1 of O395 and CA401 differs from TsiV1 of the fully
protected strain NIH41 by a single amino acid substitution,
Ile163Phe. We, therefore, replaced tsiV1 in CA401 with a
chromosomally FLAG-tagged copy of the tsiV1163Phe (A2) or
tsiV1163Ile (A1) allele to further evaluate the phenotype of this
amino acid substitution. The CA401 strain harbouring the
tsiV1163Ile allele was fully protected from the V52 T6SS, while
CA401 expressing the tsiV1163Phe allele experienced a signiﬁcant
reduction in viability analogous to the CA401 WT allele
(TsiV1163Phe = A2) (Fig. 3D). Deleting tsiV1 in the same native
CA401 background compromised survival by 3 logs as expected
(Fig. 3D). Western blot analysis of the two prey strains indicated
that CA401 produces approximately 5-fold higher levels of
TsiV1163Ile than TsiV1163Phe despite being expressed from the
same promoter. This result suggests that the 163Ile El Tor allele is
more stable than the classical TsiV1 version or that the classical
163Phe TsiV1 protein is conformationally compromised. Different half-lives may explain why TsiV1 encoded by the A1 allele is
more protective than the A2 version.
Non-AAA V. cholerae outcompete 6th pandemic classical
strains. We previously showed that V. cholerae belonging to
distinct T6SS compatibility groups compete against each other.
Those of the AAA genotype are predominately human pathogens
that outcompete all other non-AAA strains tested thus far3. We
hypothesised that 6th pandemic classical strains would be outcompeted by non-AAA strains because of the T6SS disabling
deletions in vasNΔ293-304 and vasKΔ514-521 —regardless of their
tsiV1 allele as long the non-AAA strain does not represent an Axx
compatibility group (e.g. groups AAB (strain MZO-2) or group
ABK (strain YB2A12). Classical 6th pandemic V. cholerae were
competed against non-AAA environmental isolates DL4211
(CEE), DL4215 (CEC), V51 (CDA) or 1587 (CDC) at a 1:1 ratio.
Non-AAA strains outcompeted CA401 and NIH41 between 103
and 104 fold compared to controls (Supplementary Fig. 5). These
results indicate that CA401 and NIH41 are sensitive to killing by
non-AAA V. cholerae, likely placing classical 6th pandemic
strains at a disadvantage in intraspeciﬁc competition with
environmental V. cholerae. The subtypes A1 and A2 do not
contribute to a difference in T6SS sensitivity, providing additional
support for our compatibility hypothesis.
Gain, loss and exchange of T6SS mutations in classical V.
cholerae strains model. Figures 1–3 demonstrate that the T6SS
gene clusters of 2nd and 6th pandemic classical strains accumulated mutations affecting their ability to assemble a functional
T6SS and, therefore, engage in interbacterial competition. Furthermore, we report that AAA and non-AAA strains outcompete
6th pandemic classical V. cholerae tested here.
Next, we compared available T6SS sequences between classical
and El Tor strains with a focus on vipA, vasE, vasK and vasN, as
well as amino acid substitutions in TsiV1 (Fig. 4A). Comparative
sequence analysis of PA1849 and twenty-six 6th pandemic
classical strains isolated over 50 years (1940–1990) highlighted
how the classical T6SS changed over time throughout multiple
pandemics. The 12-nucleotide vasN deletion is conserved in all 26
classical strains, and 24 of them also encode the 8-nucleotide
deletion in vasK. The 2nd pandemic PA1849 and its closest
phylogenetic relative, the 6th pandemic M29 strain, retained the
wild-type allele of vasK. All analysed 6th pandemic V. cholerae
other than 2nd pandemic PA1849 (i.e. 25 of 26 classical
sequences) harboured the additional two nucleotide insertion in
vasE and one nucleotide insertion in vipA (Fig. 4A and
Supplementary Fig. 1).
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Fig. 3 Classical strains harbour multiple amino acid substitutions in TsiV1. A Amino acid sequences of TsiV1 cluster into 4 groups (A1–A4): a radial tree
shows the strains that harbour one of four distinct TsiV1 alleles. B Overview of the 4 different TsiV1 sequences: the positions and the respective amino
acids that distinguish the sequences are shown. The compatibility group representing the TsiV1 immunity protein in the auxiliary cluster 1 is indicated in
parentheses. C Representative classical strains are sensitive to T6SS-mediated attack by the A1A1A1 strain V52. V52 or V52ΔvasK were mixed with the
indicated strains in a competition assay at a ratio of 1:1 and incubated for 4 h. The competitive index was calculated by dividing the ratio of indicated strain
to V52 determined at t = 4 h by the ratio determined at t = 0 h. The arithmetic mean ± standard deviation of n = 2 independent experiments, each
performed in duplicate, is shown. Statistical signiﬁcance was determined by a Student’s unpaired t-test (***p = (0.009, 0.013)). D TsiV1163Ile protects from
a T6SS-mediated attack, whereas TsiV1163Phe does not. V52 was mixed with the indicated strains in a competition assay at a ratio of 1:1 and incubated for
4 h on Lysogeny broth (LB) plates. Mean ± standard deviation of 2 independent experiments, each performed in duplicate, is shown. Statistical signiﬁcance
was determined by a Student’s unpaired t-test (****p = 6.5 × 10−6, **p = 0.0013, ns = not signiﬁcant). Prey bacteria from these experiments were
incubated alone under identical conditions and a western blot was performed to detect the production of TsiV1 via an anti-FLAG antibody. The ratio of the
signal from the FLAG antibody compared with the DnaK loading control is written underneath the respective lanes. For lanes in which a ratio could not be
calculated because TsiV1 is not FLAG-tagged in the respective strains, NA (not applicable) was used instead of a ratio. Source data are provided as a
Source Data ﬁle.

Next, representative strains of each T6SS genotype were chosen
to reconstruct the sequential order of mutations acquired within
the T6SS gene clusters of classical V. cholerae (Fig. 4B). According
to this model, the 2nd pandemic strain PA1849 codes only one of
the multiple mutations found in 6th pandemic strains, namely the
12-nucleotide deletion in vasN. Strain M29 forms an ancestral
bridge between PA1849 and the 6th pandemic strains. In addition
to the vasN mutation, M29 acquired the 2 bp insertion in vasE
and the 1 bp insertion in vipA. Next, all subsequent 6th pandemic
classical V. cholerae examined here acquired the 8 bp deletion in
vasK. The nucleotide substitution A487T in tsiV1 replaced
isoleucine with phenylalanine at position 163 of TsiV1, giving
rise to strains analogous to CA401 and O395 susceptible to
intraspeciﬁc T6SS-mediated attack within the same compatibility
group, AAA. The additional G709A nucleotide substitution in
strains such as A59 gave rise to the Ala237Thr TsiV1 allele.
In summary, our model suggests that classical strains acquired
debilitating mutations in their T6SS gene clusters in multiple,
sequential steps. Individual mutations were likely inherited
vertically from a common ancestor and propagated through the
classical population, conferring some form of advantage or,
conversely, not having detrimental effects on V. cholerae ﬁtness
until the emergence of 7th pandemic El Tor strains.

Discussion
V. cholerae of the classical biotype was responsible for the ﬁrst six
reported cholera pandemics. How El Tor strains replaced classical
V. cholerae as the sole source of contemporary pandemic cholera
remains unclear. This study investigated competitive differences
between the two biotypes to understand whether the T6SS might
have contributed to this replacement. While El Tor strains reach
higher cell densities, they express approximately 5-fold less CT
and TCP and cause milder disease symptoms than classical V.
cholerae24. We propose that classical V. cholerae did not require
the T6SS to be successful pathogens through at least ﬁve pandemics. Still, they were outcompeted by the emergence of El Tor
biotype strains that, despite lower CT and TCP expression,
encode additional virulence factors, engage in T6SS-mediated
combat and reach higher cell densities.
Pradhan and colleagues reported that in mixed cultures, El Tor
strains outnumber classical V. cholerae during stationary growth
phase and speculated that this phenotype is associated with utilisation of amino acids at higher efﬁciency in alkaline
conditions25. Additionally, in contrast to classical V. cholerae,
growth of El Tor biotype strains is enhanced by the production of
2,3-butanediol, a neutral fermentation end product that prevents
the accumulation of organic acids permitting increased El Tor
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Fig. 4 Phylogeny of V. cholerae strains and their T6SS gene clusters. A Maximum likelihood tree based on core-genome SNP sites of indicated V. cholerae
strains. Insertions, deletions and nucleotide substitutions are noted. Classical strains with the same mutations in the large cluster of the T6SS and TsiV1 are
highlighted in the same colour. The horizontal bars indicate the mean. B Schematic representation of the sequential acquisition of T6SS mutations among
representative classical V. cholerae strains. Arrows highlight the speciﬁc changes to the T6SS gene cluster.

growth rates8. These observations suggest that El Tor biotype V.
cholerae exhibits higher frugality with energetic resources than
classical biotype strains, consistent with the view that selective
pressure favours pathogens better adapted to capitalise on host
resources.
Our work suggests that classical V. cholerae lost their ability to
employ their T6SS to attack and defend themselves. Consequently, classical strains do not perform effectively in inter- and
6

intraspeciﬁc competition with El Tor and other non-classical
rivals. Classical strains lost the ability to engage in T6SS attacks as
early as the second pandemic, preventing them from killing other
prokaryotic cells, and thereby reducing competitiveness compared to V. cholerae expressing a functional T6SS.
Figure 5A–C presents a model of T6SS-mediated microbial
competition for 2nd through 7th pandemic strains hypothesised
to occur in any given ecological or host niche26,27. The 2nd
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Fig. 5 Model for the competitive behaviour of non-classical and classical V. cholerae O1 serogroup strains. Panels (A–C) depict intraspeciﬁc T6SSmediated interactions among V. cholerae strains (yellow, azure and green bacteria) and interspeciﬁc competition with heterologous pray (white bacterium)
not susceptible to killing by any classical pandemic V. cholerae due to a disabled vasNΔ293-304 allele. Classical V. cholerae are illustrated as azure bacteria, El
Tor biotype are shown in yellow and non-AAA V. cholerae are ﬁlled in green. Dashed cell outlines represent vulnerability to attack. For clarity, interactions
shown here focus exclusively on the compatibility vs vulnerability of pandemic strains (centre). A 2nd and early 6th pandemic classical V. cholerae bacteria
(azure, centre) are sensitive to T6SS-mediated attack (dashed cell outline) by non-AAA V. cholerae strains (green, top right). However, compatible
immunity proteins protect them against strains belonging to the same compatibility group (continuous cell outline) such as El Tors (yellow, top left).
Heterologous prey bacteria are unaffected by 2nd and early 6th pandemic classical V. cholerae. B Ile163Phe conversion of TsiV1 from subfamily A1 to A2
leaves 6th pandemic classical V. cholerae (azure, centre) vulnerable (dashed cell outline) to T6SS-mediated attack by El Tor (yellow, top left) in addition to
non-AAA V. cholerae (green, top right) while heterologous prey bacteria remain unaffected. C Classical strains are replaced worldwide by 7th pandemic El
Tor strains, which are compatible with each other (yellow, top left and centre), engage their T6SS successfully against incompatible non-AAA V. cholerae
(dashed green cells, top right) and are capable of killing bacterial competitors belonging to other species such as E. coli (heterologous prey) depicted below
as a white cell. D Classical V. cholerae strains (ﬁlled circles) listed chronologically by year of isolation (x-axis) are plotted against immunity to T6SSmediated attack by A1A1A1 strains (y-axis). The nucleotide change from adenosine to thymine at position 487 in tsiV1 that gave rise to TsiV1163Phe is
estimated to have spread among classicals in the 1940s. E The 7th cholera pandemic, starting in 1961, is caused by O1 serogroup strains of the El Tor
biotype; strains of the classical biotype are only isolated sporadically and have not been involved in pandemics since.

pandemic strain PA1849 and its closest 6th pandemic relative
M29 could not engage their T6SS due to the disabling vasNΔ293304 deletion. Shared immunity genes protected these early classical strains from attack by pre-7th pandemic El Tor biotype
strains27 T6SS, but not from environmental (non-AAA) V. cholerae (Fig. 5A). Further, TsiV1 Ile163Phe conversion from subfamily A1 to A2 left 6th pandemic strains sensitive to T6SS-

mediated attack by El Tor biotype V. cholerae (Fig. 5B). In contrast, the current 7th pandemic El Tor biotype strains are compatible with bacterial kin. Thus, they outcompete environmental
(non-AAA) V. cholerae and heterologous prey (Fig. 5C)28.
Deletions in vasN and subsequently vasK affect the ability to
produce a functional T6SS and predate the single nucleotide
substitutions in the immunity gene tsiV1. The A2 allele of tsiV1
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compromises protection from T6SS-mediated attack by A1A1A1
V. cholerae (Fig. 4B). According to this model, in the absence of
El Tor strains, selection against 2nd and 6th pandemic classical V.
cholerae’s inability to engage their T6SS would occur exclusively
upon interaction with non-AAA strains (Fig. 5A). One explanation for classical V. cholerae having caused ﬁve pandemics
without an active T6SS may be the existence of a yet-to-beidentiﬁed mechanism to outcompete non-AAA competitors
during the initial phases of outbreaks when pathogenic V. cholerae colonise the small intestine as a mixed population. Subsequently, a short aquatic life phase of classical strains between
hosts would further reduce interactions with non-AAA
competitors.
Pandemic and environmental strains interpret external cues in
the environment and host, adding to the complexity of interbacterial
interactions. For example, chitin is required for maximal killing by
El Tor strains allowing them to remain competitive against nonAAA V. cholerae that are far more likely to express T6SS constitutively during encounters in environmental niches27. Conversely,
another report demonstrated that intestinal mucins induce expression, and bile acids further modulate the activity of T6SS in pandemic El Tor strains26. These reports contribute towards our
understanding of the tight regulation T6SS of pandemic strains.
Synergy among V. cholerae strains capable of coexisting with
other members of their species sharing the same T6SS compatibility group includes sharing exchanged toxins and structural
tube proteins29. In contrast, toxin exchange between non-kin cells
leads to cell death without the possibility to recycle T6SS components. T6SS duelling contributes to kin selection and enhances
the ability of kin bacteria to colonise environmental and host
niches3,28.
The disadvantages of lacking T6SS activity include the inability
to battle intra- and interspeciﬁc competitors and, consequently,
the decreased uptake of exogenous DNA30–32, reduced resistance
to conjugation33 and the failure to deploy anti-eukaryotic
effectors2. One signiﬁcant advantage from the loss of T6SS
activity among classical strains is the energetic investment that
biosynthesis of structural components demands on cell metabolism at the expense of motility and virulence factor production.
The absence of Hcp protein synthesis among 6th pandemic V.
cholerae supports this hypothesis (Supplementary Fig. 6). Lack of
T6SS activity may also contribute towards immune avoidance of
secreted antigens, thereby facilitating colonisation persistence24.
Furthermore, a strain unable to engage its T6SS triggers fewer
retaliatory events from competing bacteria (a phenomenon
known as tit-for-tat), thereby increasing chances for survival in
select interspeciﬁc encounters34.
The loss of T6SS immunity (Fig. 5B) was not selected against
until the emergence of El Tor V. cholerae (Fig. 5C, E). The
deletions that incapacitated T6SS engagement removed the
pressure to maintain full immunity among kin strains, permitting
the mutations to debilitate T6SS immunity genes without
immediate consequence (Fig. 5D). Perhaps not coincidentally, El
Tor strains became pandemic after classical V. cholerae progressively lost their ability to express the T6SS apparatus and further
became susceptible to T6SS-mediated attack by A1A1A1 kin such
as those of the El Tor biotype. It is tempting to speculate that
these events and other biotype-speciﬁc features contributed to the
observed reduction in classical strains isolated, as their persistence
in environmental niches is hampered by their inability to engage
and defend against T6SS attacks by any other V. cholerae. Collectively, these factors may have supported the emergence and
persistence of El Tor strains as the cause of pandemic cholera
(Fig. 5E).
Our study support the idea that intraspeciﬁc microbial competition and compatibility among bacterial strains is critical for
8

Table 1 List of Vibrio cholerae strains used in this study and
their reference/sourcea.
Strain name

Reference

PA1849
O395

This study
John Mekalanos (Harvard Medical School,
Boston, MA, USA)

C6706
V52
V52ΔvasK
V52vasKΔ514-521
V52vasNΔ293-304
AM-19226
CA401
CA401ΔtsiV1
CA401tsiV1163Phe -FLAG
CA401tsiV1163Ile-FLAG
NIH41

50

DL4211
DL4215
V51

28

1587

53

aGene

51
2

This study
This study
52

Shelley Paine (University of Texas at Austin)
This study
This study
This study
John Mekalanos (Harvard Medical School,
Boston, MA, USA)
28

Michelle Dziejman (University of Rochester,
New York)

names in italics.

understanding the succession of pathogenic agents of the same
species.
Methods
Strains and culture conditions. Vibrio cholerae and E. coli strains were grown in
Lysogeny broth (LB) (1% tryptone, 0.5% yeast extract, 0.5% NaCl) at 37 °C shaking
or on LB agar plates (supplemented with 1.5% agar). Bacteria were grown in the
presence of 100 µg/mL ampicillin, 100 μg/mL streptomycin or 50 µg/mL rifampicin. The strains used in this study are described in Table 1.
Molecular cloning. The in-frame deletion mutant CA401ΔtsiV1 was constructed
as described previously using pWM91-based knockout constructs35. Knock-in
versions of PA1849 alleles of vasK and vasN were made using the same approach.
Table 2 lists the primers employed to construct all mutant strains.
Competition assay. Competition assays were performed as described previously21.
Brieﬂy, two V. cholerae strains or a V. cholerae strain and E. coli MG1655 were
mixed at indicated ratios and incubated on pre-dried LB agar plates. After a 4 h
incubation at 37 °C, bacteria were harvested, serially diluted and plated onto LB agar
plates supplemented with selective antibiotics to enumerate surviving V. cholerae or
E. coli bacteria. The next day, colony-forming units (CFUs) were counted.
Western blot analysis. Samples for western blots were prepared by growing
bacteria in LB to the mid-logarithmic phase of growth, harvesting cells and normalising the OD600 to 1.0. Cell pellets from mid-logarithmic growth phase bacterial
cultures were resuspended in PBS/2X lysis buffer, boiled and centrifuged. Supernatants were loaded and electrophoresed in either 12% or 15% acrylamide SDSPAGE at 120 V before transfer to nitrocellulose. After blocking in dry milk/1X
TBST for 1 h, blots were probed with primary antibodies diluted to 1:5000 (antiFLAG), 1:500 (anti-Hcp) or 1:10,000 (anti-DnaK) followed by probing with
ﬂuorescently labelled secondary antibodies diluted at 1:10,000. Images were captured with a LICOR Odyssey scanner and analysed using Image Studio Lite software (Supplementary Fig. 11).
RNA isolation, cDNA synthesis and RT-PCR. RNA from bacterial cultures grown
to the mid-logarithmic phase of growth was extracted using TRIzol reagent
(Invitrogen), treated with DNase I (Invitrogen) and transcribed into cDNA using
the SuperScript III Reverse Transcriptase (Invitrogen). Quantitative real-time PCR
(qPCR) was performed with the SensiFAST SYBR No-ROX Kit (FroggaBio) using
the CFX96 Real-Time System (Biorad). Thermocycling parameters were as follows:
95 °C for 2 min hot start, 40 cycles at 95 °C for 15 s, and 60 °C for 1 min followed
by a melting curve. Primers to genes of interest were designed using PrimerQuest
software from Integrated DNA Technologies (IDT). Primers were tested for performance in qPCR with a cDNA concentration gradient, and those with slopes
between −3.3 and −3.7, the efﬁciency of ∼1.0 and R2 of ∼1.0 were used in the
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Table 2 A list of primers used in this studya.
Primer name

Sequence

vasN-F
vasN-R
vasK-A
vasK-B
vasK-C
vasK-D

TTTATTGCTCTTACTATGCGTAAAGGC
CATAGACATTCTTTGGATAAGGCAGC
AATACGACTCACTATAGGGCGAATTGGGTAAAGAGGCGTTTCAACTGGC
TCAGGACAGATTCATCACCAATCAAACGAGTATGGGTT
CTCGTTTGATTGGTGATGAATCTGTCCTGATTGATCCTGA
ATTAACCCTCACTAAAGGGAACAAAAGCTGTTGCGTGAAATAGACCGTGG

aGene

names in italics.

qPCR studies. All primers employed here are listed in Table 2. Expression of tsiV1
relative to 16 s rRNA control was determined by the 2−ΔΔCT method using the
CFX Manager Software (Biorad). The resulting relative quantiﬁcation (RQ) values
of all samples were normalised against expression of strain C6706.
PA1849 DNA extraction. We analysed tissue collected from a single intestinal
sample (specimen 3090.13) taken from a cholera patient in Philadelphia in 1849
and archived by the Mütter Museum in Philadelphia, PA, USA. The Mütter
Museum approved sampling and analysing this sample. All tissue handling and
library preparation (before indexing ampliﬁcation) were performed in a positivepressurised ancient DNA-appropriate laboratory at Arbor Biosciences in which no
human or cholera tissue handling or library preparation had previously been
performed. We employed ﬁeld-appropriate standards of anti-contamination
technique, including the use of full-body suits, frequent bleach-based work surface
and tool decontamination, and blank extraction reactions containing only reagents
without template.
Two 5 × 5 mm squares (Supplementary Fig. 7) were cut from the intestinal
specimen using decontaminated tweezers and unused razor blades and placed in
2 mL microcentrifuge tubes. An open tube was kept near the processing area
during this sub-sampling procedure to serve as another extraction blank.
Each sample was digested with 750 μL solution comprised of 2.5 mM EDTA,
5 mM Tris-Cl, 0.5% SDS, 0.25 ng/μL Proteinase K, which exhibited a ﬁnal pH of 8.5
after introduction to the dried tissue specimen. After 17 h of incubation at 37 °C,
each sample was placed at 4 °C for 4 h, and then 500 μL of the resulting ﬂuid was
taken to puriﬁcation using method B from Glocke & Meyer, 201736, with ﬁnal
eluates of 100 μL TET buffer.
Library preparation. Roughly 36 ng total tissue DNA extract (15 μL) was taken to
library preparation and indexing ampliﬁcation using the Swift Biosciences (Ann
Arbor Michigan) Accel-NGS(R) Methyl-Seq DNA Library Kit following the
manufacturer’s standard procedure. The library was index-ampliﬁed 10 cycles
using dual 8 bp-indexing primers.
Probe design. Two distinct probe sets were designed for this project, one designed
to enrich the entire cholera genome, and another targeting only the three T6SS
clusters. The whole-genome kit tiled 80 nt probes every 20 nt across both V. cholerae O395 genome reference chromosomes (NCBI Accessions NC_009456 and
NC_009457) following soft-masking regions annotated as repeat elements. Where
probes overlapped regions of known SNPs in PA1849, probes containing those
SNPs were also included (n = 203). Any probe candidate that overlapped 20 nt or
more with annotated repeat regions, or that had multiple strong hybrid sites in the
genome were eliminated from the design. This resulted in a ﬁnal set of 186,228
probes. A similar procedure was used for the T6SS probe set, starting with the V.
cholerae T6SS auxiliary 1, auxiliary 2 and large loci as references for probe design,
and probes for putative PA1849 SNPs included as well (n = 2). This ﬁnal set
comprised 2876 probes.
Target enrichment. Target enrichment used a combination of whole-genome and
T6SS probes at a mass ratio of 99% whole-genome, 1% T6SS or exclusively T6SS
probes. Depending on library availability, between 75 and 1000 ng of sample, or 2
and 500 ng of extraction blank library, were taken to enrichment using the myBaits
protocol version 3.0. This involved a ﬁrst round of overnight hybridisation at 60 °C
and a single Wash Buffer 2 hot wash, followed by post-capture ampliﬁcation of
80% of the resulting volume of bead-bound enriched libraries for 14 cycles prior to
puriﬁcation. Then the enriched libraries were taken to a second round of enrichment using identical conditions as the ﬁrst, except three washes were used during
cleanup. Half of the available volume of bead-bound library was taken to 8 cycles of
ampliﬁcation prior to puriﬁcation. These double-enriched libraries were then
submitted for sequencing. Enriched and non-enriched versions of each library were
then sequenced using PE100 protocol on a HiSeq 2500 lane, demultiplexed by dual
8 bp barcodes.

Construction of PA1849 genome. The following analyses were performed on
sequencing reads produced with (SL264753) and without (SL264742) target
enrichment. Enriched sequencing reads (SL264753) were used to generate consensus sequences and identify variant loci due to signiﬁcantly increase coverage
over the T6SS clusters.
Raw PA1849 FASTQ ﬁles were QC validated with FastQC (v0.11.9) to assess
Phred quality score and nucleotide distribution over reads. The forward adapter
(AGATCGGAAGAGCACACGTCTGAACTCCAGTCA) and the reverse adapter
(AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT) were removed from
paired-end read ﬁles, and ends were trimmed with a Phred quality score cut-off of
30 using cutadapt (v1.16). Reads below a minimum length cut-off of 30 nucleotides
were removed. Overlapping paired-end reads from the trimmed FASTQ ﬁles were
merged into single-end reads with NGmerge (v0.2)37. Merged reads were aligned to
a reference FASTA with the Burrows-Wheeler Aligner (bwa v0.7.17) MEM
algorithm38. For analysis of the T6SS loci, reference FASTA ﬁles were constructed
by concatenating genomic islands extracted from C6706 (PacBio sequence of
laboratory stock) or O395 (PacBio sequence of laboratory stock) with 100
nucleotide spacers between each region. For phylogenetic analysis, reads were
mapped to the whole-O395-genome. SAM ﬁles produced were then sorted and
marked for duplicates with Picard Tools (v2.17.11) to generate sorted, unique BAM
ﬁles, which were indexed with Picard Tools39. Variants were called against the
constructed reference FASTA, and consensus sequences were generated with Pilon
(v1.22)40. For analysis of the T6SS loci, PA1849 consensus sequences were aligned
to C6706 and O395 reference sequences using the progressive MAUVE algorithm
(v1.1.1) algorithm in Geneious (v2019.0.4), assuming colinear genomes. Genome
coverage plots were generated from sorted, unique BAM ﬁles uploaded to the
Integrative Genomics Viewer (v2.9.4).
Assessing damage proﬁle of PA1849 reads. Mapped reads from the sorted,
unique BAM ﬁles were assessed for fragment length distribution (Supplementary Fig. 8). The median fragment length of >150 bp is higher than the 40 bp
length from Devault et al.1, because of a difference in Illumina chemistry, lack
of sonication of the tissue and enrichment with our updated T6SS probes.
Nucleotide substitution patterns characteristic of ancient DNA samples (Supplementary Fig. 9) with mapDamage (v2.0)41. Canonical damage patterns
typical of ancient DNA (C > T substitutions at the 5′ fragment end and G > A
substitutions and the 3′ fragment end) were not observed for these samples. A
low frequency of C > T substitutions can be seen at either end of the mapped
reads (Supplementary Fig. 9).
Core-genome phylogeny and genomic alignments. Core-genome-based phylogenetic trees were constructed as follows: Genomic FASTA ﬁles for tree building
were obtained from the PATRIC database or NCBI (Table 3) and annotated using
Prokka (v1.12)42. A core genome was extracted from Prokka-output GFF3 ﬁles
using Roary (v3.11.2)43 with a minimum blastp percentage identity of 95% for
calling core genes. Roary extracted and aligned 688 core genes (present in >99% of
analysed strains). The core-genome alignment was reduced to only loci harbouring
polymorphisms using SNP sites (v2.4.1)44. A total of 6,225 distinct SNP sites were
extracted from the 688 core genes. A Maximum Likelihood phylogenetic tree was
built using the RAxML (v8.2.12) GTR model. Model was selected using jModelTest
(v0.1.6)45. Statistical branch support was obtained from 100 bootstrap repeats.
Phylogenetic trees were visualised from RAxML-generated newick ﬁles using
TreeGraph 2 (v2.15.0-887 beta)46. Branches with bootstrapping support values <70
were collapsed. Alignments of amino acid sequences were performed with MUSCLE (v3.8.425)47 and alignments of the nucleotide sequences of whole-gene clusters were performed using the progressive MAUVE algorithm48 in Geneious
(Geneious Prime v2019.0.4). To display the diversity of amino acid sequences as a
radial tree, aligned sequences were analysed using RAxML (nucleotide model: GTR
Gamma, Algorithm: Rapid hill-climbing)49 and displayed with Geneious Prime
(v2019.0.4). Some genomes were poorly assembled over the T6SS clusters, and thus
corresponding read ﬁles from SRA (Table 3) were aligned to the O395 and C6706
T6SS cluster reference sequences in Geneious Prime (v2019.0.4) to determine
consensus sequences and identify polymorphisms.
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Table 3 A list of genomes and reads used in this study.

6.

Strain

Accession

SRA accession

7.

2740-80
NCTC 8457
M66-2
MAK 757
A6
IEC224
A1552
C6706
N16961
MO10
2010EL-1786
MJ-1236
V52
PA1849
M29
A46
A51
A59
A68
A111
RC27
D-35
A57
A61
A49
A50
A60
O395
O1 str. 95412
GP8
GP16
A70
A76
A66
A389
A103
A279

GCA_001683415.1
GCA_000153945.1
GCA_000021605.1
GCA_000153865.1
GCA_001255575.1
GCA_000250855.1
GCA_002892855.1
GCA_013085075.1
GCA_000006745.1
GCA_000152425.1
GCA_000166455.2
GCA_000022585.1
GCA_000167935.2
NA
GCA_000709105.1
GCA_001259555.1
GCA_001253435.1
GCA_001254535.1
GCA_001259635.1
GCA_001253495.1
GCA_000176395.1
GCA_000961975.1
GCA_001250255.1
GCA_001250935.1
GCA_001253835.1
GCA_001254735.1
GCA_001248195.1
GCA_000016245.1
GCA_000348105.2
GCA_001253575.1
GCA_001251495.1
GCA_001248905.1
GCA_001259495.1
GCA_001260915.1
GCA_001259795.1
GCA_001254575.1
GCA_001253555.1

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
PRJNA767369
NA
ERR018132
ERR018141
ERR018139
ERR018135
ERR018155
NA
NA
ERR018140
ERR018137
ERR018134
ERR018142
ERR018138
NA
NA
NA
NA
ERR018133
ERR018143
ERR018136
ERR018178
ERR018145
ERR018173

8.
9.

10.

11.

12.

13.
14.

15.
16.

17.
18.
19.
20.

21.

22.
23.

24.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

25.

Data availability
The raw reads for the PA1849 T6SS gene clusters are available in the NCBI SRA database
under the BioProject accession number PRJNA767369. The data generated in this study
are provided in the Supplementary information/Source Data ﬁle. Source data are
provided with this paper.

26.
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